Condensed Consolidated Statement of Shareholders' Investment (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Increase (Decrease) in Shareholders' Investment
Beginning balance	$ 38,827
Net earnings	1,225	$ 1,318
Other comprehensive income (loss)	(327)	12
Ending balance	39,043
Common Shares
Increase (Decrease) in Shareholders' Investment
Beginning balance	24,869	24,709
Issued under incentive stock programs	87	16
Share-based compensation	322	296
Issuance of restricted stock awards	(552)	(533)
Ending balance	24,726	24,488
Common Shares Held in Treasury
Increase (Decrease) in Shareholders' Investment
Beginning balance	(15,981)	(15,229)
Issued under incentive stock programs	242	242
Purchased	(22)	(320)
Ending balance	(15,761)	(15,307)
Earnings Employed in the Business
Increase (Decrease) in Shareholders' Investment
Beginning balance	37,554	35,257
Net earnings	1,225	1,318
Cash dividends declared on common shares	(960)	(890)
Effect of common and treasury share transactions	192	183
Ending balance	38,011	35,868
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Shareholders' Investment
Beginning balance	(7,839)	(8,051)
Other comprehensive income (loss)	(327)	12
Ending balance	(8,166)	(8,039)
Noncontrolling Interests in Subsidiaries
Increase (Decrease) in Shareholders' Investment
Beginning balance	224	219
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases	9	3
Ending balance	$ 233	$ 222